G. James

First name
G.
Last name
James
Little, D. J., Arnold, M., Hedman, K., Sun, P., Haque, S. A., & James, G. (2023). Rates of adverse clinical events in patients with chronic kidney disease: analysis of electronic health records from the UK clinical practice research datalink linked to hospital data. Bmc Nephrol, 24, 91. http://doi.org/10.1186/s12882-023-03119-z
View
Pollock, C., James, G., Sanchez, J. J. G., Carrero, J. J., Arnold, M., Lam, C. S. P., et al. (2022). Healthcare resource utilisation and related costs of patients with CKD from the UK: a report from the DISCOVER CKD retrospective cohort. Clin Kidney J, 15, 2124-2134. http://doi.org/10.1093/ckj/sfac168
View
James, G., Sanchez, J. J. G., Carrero, J. J., Kumar, S., Pecoits-Filho, R., Heerspink, H. J. L., et al. (2022). Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility. Kidney Int Rep, 7, 2059-2070. http://doi.org/10.1016/j.ekir.2022.05.033
View
James, G., Kim, J., Mellström, C., Ford, K. L., Jenkins, N. C., Tsang, C., et al. (2022). Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study. Clin Kidney J, 15, 758-770. http://doi.org/10.1093/ckj/sfab225
View
Tafesse, E., Hurst, M., Hoskin, L., Badora, K., Sugrue, D., Qin, L., et al. (2020). Risk factors associated with the incidence and recurrence of hyperkalaemia in patients with cardiorenal conditions. Int J Clin Pract. http://doi.org/10.1111/ijcp.13941
View
Humphrey, T. J. L., James, G., Wittbrodt, E. T., Zarzuela, D., & Hiemstra, T. F. (2021). Adverse clinical outcomes associated with RAAS inhibitor discontinuation: analysis of over 400 000 patients from the UK Clinical Practice Research Datalink (CPRD). Clin Kidney J. http://doi.org/10.1093/ckj/sfab029
View